Prosthesis (i.e. – artificial body members) – parts thereof – or ai – Implantable prosthesis – Hollow or tubular part or organ
Reexamination Certificate
2007-02-13
2007-02-13
McDermott, Corrine (Department: 3738)
Prosthesis (i.e., artificial body members), parts thereof, or ai
Implantable prosthesis
Hollow or tubular part or organ
C623S023650, C623S023750
Reexamination Certificate
active
11222666
ABSTRACT:
A porous weave of bioabsorbable filaments is encased in an elastic membrane to form a thin-walled stent. The stent is sized to be snugly fitted in the proximate portion of the duodenum of a patient, to induce weight loss by limiting uptake of food passing through the stent. After a predetermined period, the stent degrades and passes from the body without surgical intervention.
REFERENCES:
patent: 4315509 (1982-02-01), Smit
patent: 4648383 (1987-03-01), Angelchik
patent: 5306300 (1994-04-01), Berry
patent: 2002/0161341 (2002-10-01), Stinson et al.
patent: 2003/0040804 (2003-02-01), Stack et al.
Benjamin, S.B., et al., “Double-Blind Controlled Trial of the Garren-Edwards Gastric Bubble: An Adjunctive Treatment for Exogenous Obesity,”Gastroenterology 95(3):581-588, Sep. 1988.
Coelho, J.C.U., and Campos, A.C.L., “Surgical Treatment of Morbid Obesity,”Current Opinion in Clinical Nutrition and Metabolic Care 4(3):201-206, May 2001.
Hubert, H.B., et al., “Obesity as an Independent Risk Factor for Cardiovascular Disease: A 26-year Follow-up of Participants in the Framingham Heart Study,”Circulation 67(5):968-977, May 1983.
Kral, J.G., “Gastric Balloons: A Plea for Sanity in the Midst of Balloonacy,”Gastroenterology 95(1): 213-215, Jul. 1998.
Kral, J.G., “Overview of Surgical Techniques for Treating Obesity,”American Journal of Clinical Nutrition 55(2):552S-555S, 1992.
Macgregor, A.M.C., and Rand, C.S.W., “Gastric Surgery in Morbid Obesity,”Archives of Surgery 128(10):1153-1157, Oct 1993.
MacLean, L.D., et al., “Results of the Surgical Treatment of Obesity,”The American Journal of Surgery 165:155-162, Jan. 1993.
Mathus-Vliegen, E.M.H., et al., “Intragastric Balloon in the Treatment of Super-morbid Obesity,”Gastroenterology 99(2):362-369, Aug. 1990.
Meshkinpour, H., et al., “Effect of Gastric Bubble as a Weight Reduction Device: A Controlled, Crossover Study,”Gastroenterology 95(3):589-592, Sep. 1988.
Mun, E.C., et al., “Current Status of Medical and Surgical Therapy for Obesity,”Gastroenterology 120(3):669-681, Feb. 2001.
Pi-Sunyer, F.X., “Medical Hazards of Obesity,”Annals of Internal Medicine 119(7):655-660, Oct. 1993.
Boston Scientific Corporation
Christensen O'Connor Johnson & Kindness PLLC
Matthews William H
McDermott Corrine
LandOfFree
Intragastric stent for duodenum bypass does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Intragastric stent for duodenum bypass, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Intragastric stent for duodenum bypass will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3840654